Product Information
TIAGABINE HCL 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.2056 per EA under NDC 00093503056. Its NADAC has been published 321 times since Jul 13, 2016.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093503056
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020646On Market Since
6/3/2016
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 2 MG TABLET has been published 321 times since Jul 13, 2016, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2056 per EA |
|---|---|
| All-time high | $5.1011 (Jul 12, 2017) |
| All-time low | $1.8447 (Mar 18, 2026) |
| 52-week high | $2.2056 |
| 52-week low | $1.8447 |
| Median price | $4.0911 |
| Average price | $3.6118 |
| Largest weekly change | -47.4% (Jan 17, 2024) |
| Weeks tracked | 321 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $2.2056 per EA (NDC 00093503056), effective Jun 24, 2026.
How has the price of TIAGABINE HCL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 2 MG TABLET has declined 56.8%. It has been tracked across 321 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 2 MG TABLET?
Since Jul 13, 2016, the NADAC for TIAGABINE HCL 2 MG TABLET has ranged from a low of $1.8447 (Mar 18, 2026) to a high of $5.1011 (Jul 12, 2017), with a median of $4.0911 per EA.
Are there cheaper alternatives to TIAGABINE HCL 2 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TIAGABINE HCL 2 MG TABLET, but none are currently priced below it.
Who manufactures TIAGABINE HCL 2 MG TABLET?
TIAGABINE HCL 2 MG TABLET (NDC 00093503056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification